Stretch Marks Treatment Market Report

Global Stretch Marks Treatment Market Size

In 2024,the global stretch marks treatment market size was valued at USD 2.56 billion and it is expected to reach USD 4.95 billion by 2033 from USD 2.75 billion in 2025, growing at a CAGR of 7.6 % during the forecast period.

The stretch marks treatment market covers a range of therapeutic and cosmetic interventions designed to reduce the appearance of striae, which are caused by rapid stretching of the skin due to weight gain, pregnancy, puberty, or bodybuilding. These treatments include topical creams and lotions, laser therapies, microdermabrasion, radiofrequency treatments, and injectable solutions that stimulate collagen production and improve skin elasticity.

According to the American Academy of Dermatology (AAD), more than 90% of pregnant women develop stretch marks during or after pregnancy, making this one of the most common dermatological concerns globally. In addition, rising obesity rates, increased awareness about aesthetic treatments, and growing consumer interest in non-invasive procedures have collectively fueled demand for effective stretch mark management solutions.

As per the World Health Organization (WHO), global obesity prevalence has nearly tripled since 1975, with over 650 million adults classified as obese in 2023. This trend has significantly contributed to the number of individuals experiencing stretch marks, particularly among younger populations seeking improved skin appearance through medical and cosmetic interventions.

Moreover, the expansion of telemedicine and digital skincare consultations has made it easier for consumers to access personalized treatment recommendations. With social media amplifying beauty consciousness and influencing self-perception, the demand for safe and effective stretch marks treatments is on an upward trajectory across both clinical and at-home care settings, positioning this market as a growing segment within the broader dermatology and aesthetics industry.

MARKET DRIVERS

Rising Obesity and Weight-Related Skin Conditions

A primary driver of the stretch marks treatment market is the increasing prevalence of obesity and associated weight fluctuations, which contribute significantly to the development of stretch marks. As individuals undergo rapid weight gain followed by weight loss—often through bariatric surgery or intensive fitness regimens—the skin stretches beyond its elastic limit, leading to dermal damage and scarring.

In the United States alone, according to the Centers for Disease Control and Prevention (CDC), nearly 42% of adults were obese, contributing to a surge in post-weight-loss patients seeking corrective skin treatments.

This trend is not only limited to adults; childhood obesity has also been on the rise.

Moreover, dermatologists and aesthetic clinics are increasingly offering combination therapies such as fractional lasers, microneedling, and topical retinoids tailored for stretch mark reduction. As public health initiatives continue to address obesity, the parallel demand for skin restoration treatments is expected to grow, reinforcing the role of weight-related factors in driving the stretch marks treatment market.

Increasing Awareness and Acceptance of Aesthetic Treatments

An additional key driver fueling the growth of the stretch marks treatment market is the heightened awareness and acceptance of aesthetic procedures among diverse demographic groups. Social media platforms, influencer marketing, and direct-to-consumer advertising have played pivotal roles in normalizing discussions around body image concerns and encouraging individuals to seek professional treatment options.

According to the American Society of Plastic Surgeons (ASPS), there was a 22% increase in minimally invasive aesthetic procedures between 2020 and 2023, with stretch mark treatments being among the top five sought-after skin enhancement services. Millennials and Gen Z consumers, in particular, are showing greater openness to cosmetic dermatology, with online engagement and peer testimonials playing a crucial role in decision-making.

Besides, the availability of at-home stretch mark treatment products including specialized oils, serums, and dermarollers have broadened accessibility and encouraged early intervention. Companies like Curology and Neutrogena have launched targeted skincare lines backed by dermatological research, further integrating stretch mark care into mainstream beauty routines.

Moreover, the normalization of body positivity combined with the desire for improved skin texture has expanded the target audience beyond traditional users. As awareness continues to grow, so does the demand for both clinical and consumer-grade stretch marks treatments, reinforcing this as a powerful growth catalyst for the market.

MARKET RESTRAINTS

Limited Clinical Efficacy and Variable Treatment Outcomes

A significant restraint affecting the stretch marks treatment market is the variability in clinical efficacy and inconsistent outcomes associated with available treatment modalities. While numerous products and procedures claim to reduce the visibility of stretch marks, scientific validation remains limited, and results often vary based on individual skin type, severity of striae, and adherence to treatment protocols.

According to the British Journal of Dermatology, many over-the-counter topical treatments lack robust clinical trials supporting their effectiveness.

In the realm of professional treatments, laser therapy and microneedling have shown promise, but results can be temporary or require multiple sessions to achieve visible effects. As per the Journal of Cosmetic Dermatology in 2023, only about 40% of patients reported noticeable improvement after undergoing three or more laser treatments, raising questions about cost-effectiveness and long-term sustainability.

These limitations contribute to hesitancy among potential users, especially those seeking immediate and lasting results. Without stronger evidence-based support and standardized outcome measurements, the market faces challenges in gaining widespread medical endorsement and consistent consumer trust.

High Cost of Professional Treatments and Lack of Insurance Coverage

Another critical constraint impacting the stretch marks treatment market is the high cost associated with professional dermatological interventions, coupled with the general exclusion of these treatments from insurance coverage.

The financial burden limits access primarily to affluent individuals, excluding a large portion of the population that experiences stretch marks due to pregnancy, weight changes, or adolescent growth spurts.

Insurance companies generally categorize stretch mark treatments as cosmetic rather than medical, resulting in minimal reimbursement opportunities. As per the National Institute for Health Care Management (NIHCM), less than 5% of private insurers in the U.S. covered any form of stretch mark removal therapy, even when prescribed by dermatologists.

While affordable at-home alternatives are emerging, they often fail to deliver the same level of efficacy as professional treatments.

MARKET OPPORTUNITIES

Expansion of At-Home and Over-the-Counter Solutions

A major opportunity emerging in the stretch marks treatment market is the expanding availability of at-home and over-the-counter (OTC) skincare solutions aimed at improving skin texture and reducing the visibility of striae. Consumers are increasingly seeking accessible, affordable, and convenient treatment options that can be incorporated into daily skincare routines without requiring frequent visits to dermatologists or aesthetic clinics.

Brands have capitalized on this trend by introducing scientifically backed formulations containing peptides, hyaluronic acid, and plant-based oils known to enhance skin elasticity and hydration.

Furthermore, the integration of digital dermatology platforms allows consumers to receive virtual consultations and personalized product recommendations. Companies like Curology and First Derm have introduced AI-powered skin analysis tools that guide users toward suitable topical treatments, enhancing customer engagement and brand loyalty.

With rising consumer confidence in self-care approaches and the proliferation of e-commerce channels, the at-home stretch marks treatment sector is poised for strong growth, offering manufacturers new revenue streams and broader market reach beyond traditional clinical settings.

Integration of Regenerative Medicine and Biotechnology Innovations

An exciting opportunity in the stretch marks treatment market lies in the application of regenerative medicine and biotechnological advancements to restore damaged skin at a deeper, cellular level. Innovations such as stem cell therapy, platelet-rich plasma (PRP), and bioengineered skin substitutes are opening new frontiers in treating stretch marks beyond superficial interventions.

According to the International Society for Stem Cell Research (ISSCR), several clinical studies conducted in 2023 explored the use of adipose-derived stem cells in combination with microneedling to regenerate dermal tissue and improve skin integrity. Early-stage trials showed promising results, particularly in reducing redness and improving skin texture in early-stage stretch marks.

Also, biotech firms are developing novel formulations using growth factors and extracellular matrix components to accelerate tissue repair and stimulate collagen production. As per the Journal of Investigative Dermatology in 2023, synthetic epidermal growth factor (EGF)-based serums demonstrated measurable improvements in skin firmness and elasticity among test subjects with moderate stretch marks.

Cosmeceutical brands are also partnering with research institutions to commercialize these breakthroughs in user-friendly formats. As biotechnology converges with dermatology, the stretch marks treatment market is entering a new era of science-driven, long-term solutions that could redefine current treatment paradigms and attract a broader patient base.

MARKET CHALLENGES

Regulatory Scrutiny and Product Approval Delays

Among the foremost challenges facing the stretch marks treatment market is the increasing regulatory scrutiny surrounding the claims made by cosmetic and dermatological product manufacturers. Regulatory agencies such as the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have intensified their oversight on products that make anti-aging, skin-repair, or scar-reduction claims, particularly when supported by limited clinical data.

This tightening of standards has led to longer development cycles and higher compliance costs for companies aiming to bring new products to market.

In Europe, the Cosmetics Regulation (EC No 1223/2009) has imposed stricter requirements on ingredient safety and labeling accuracy, forcing manufacturers to invest in additional testing before launching new formulations. These regulatory complexities have slowed the introduction of innovative treatments, particularly for small and mid-sized companies lacking extensive R&D budgets.

As regulators push for higher transparency and evidence-based substantiation, the challenge of navigating approval processes while maintaining competitive innovation timelines remains a pressing issue for players in the stretch marks treatment market.

Consumer Skepticism and Perception of Low Permanence

Another pressing challenge confronting the stretch marks treatment market is consumer skepticism regarding the permanence and overall effectiveness of available treatments. Many individuals who suffer from stretch marks—whether due to pregnancy, weight fluctuation, or hormonal changes—are often disillusioned by inconsistent results and exaggerated marketing claims, leading to low repeat purchase rates and reluctance to invest in premium solutions.

According to a 2023 survey conducted by the American Academy of Dermatology (AAD), only 34% of respondents believed that stretch marks could be effectively treated, with many reporting dissatisfaction with previous attempts at home remedies and topical applications. This perception of limited success discourages potential customers from engaging with either professional or consumer-level treatments, despite ongoing product innovation.

Furthermore, the transient nature of stretch marks—particularly in early stages where red or purple striae may fade naturally—has led some consumers to question the necessity of expensive interventions. To combat this skepticism, companies must focus on transparent communication, real-world case studies, and physician-endorsed education to build trust and encourage sustained investment in stretch marks treatment solutions.

REPORT COVERAGE

SEGMENTAL ANALYSIS

By Treatment Insights

Lasers represented the largest segment in the stretch marks treatment market, capturing 56.6% of total revenue in 2024. This dominance is attributed to the increasing adoption of advanced laser technologies such as fractional CO2, erbium-doped lasers, and pulsed dye lasers that offer targeted skin regeneration and improved collagen production.

Also, a key driver behind this segment's leadership is the growing consumer preference for minimally invasive procedures that provide visible results with minimal downtime.

Additionally, dermatologists and aesthetic specialists increasingly recommend laser therapy due to its ability to stimulate elastin and collagen synthesis, thereby enhancing skin texture and reducing discoloration. The British Journal of Dermatology reported in 2023 that patients undergoing fractional laser treatments experienced notable improvement in early-stage stretch marks compared to other modalities. With continuous advancements in laser technology—such as picosecond lasers offering enhanced pigment targeting—and rising disposable incomes supporting elective treatments, the laser segment remains at the forefront of the stretch marks treatment market.

Microdermabrasion is emerging as the fastest-growing treatment modality in the stretch marks treatment market, projected to expand at a CAGR of around 9.7%. This growth is driven by the procedure’s affordability, accessibility, and suitability for mild to moderate cases of striae.

Unlike more intensive laser therapies, microdermabrasion is a non-invasive exfoliation technique that removes dead skin cells and stimulates new cell growth without requiring recovery time.

Moreover, the expansion of home-use microdermabrasion devices has significantly broadened market reach. Companies like PMD Personal Microderm and Neutrogena have introduced handheld tools that mimic professional-grade exfoliation, making the treatment more accessible to consumers seeking gradual improvements.

As per the Journal of Cosmetic Dermatology in 2023, microdermabrasion, when used in conjunction with topical retinoids or peptides, showed measurable benefits in early-stage stretch mark reduction. So, with rising interest in at-home aesthetics and cost-effective solutions, microdermabrasion is poised for sustained growth across both clinical and consumer-driven settings.

By End User Insights

Clinics led the stretch marks treatment market, accounting for 39.6% of total revenue in 2024. These include general aesthetic clinics, medical spas, and private dermatology practices that offer a wide range of skin rejuvenation services tailored to individual needs.

A primary aspect driving this segment's dominance is the accessibility of personalized treatment options combined with professional guidance. According to the American Med Spa Association, nearly 60% of all cosmetic skin treatments in the U.S. were administered through outpatient clinics in 2023, with stretch mark reduction being one of the top five requested procedures.

Apart from these, the rise of medispa models—where non-surgical aesthetic enhancements are offered under medical supervision—has contributed to increased clinic-based service uptake.

Furthermore, insurance-covered consultations in some regions allow patients to receive expert assessments before proceeding with paid treatments, reinforcing clinic engagement as a preferred pathway. With continued expansion of aesthetic-focused healthcare centers, clinics remain central to the stretch marks treatment landscape.

Home-use products are experiencing the highest growth rate in the stretch marks treatment market, anticipated to expand at a CAGR of approximately 12.5%. This surge is fueled by rising consumer interest in self-care beauty regimens, digital dermatology consultation platforms, and the availability of affordable, effective at-home treatment options.

Brands have expanded their product lines to include clinically tested ingredients such as hyaluronic acid, rosehip oil, and centella asiatica extract designed specifically for stretch mark prevention and mitigation.

Also, e-commerce platforms have made these products more accessible, allowing consumers to purchase high-quality skincare items without visiting a clinic. As telemedicine continues to support virtual skin assessments and AI-powered recommendation engines personalize skincare routines, home-use solutions are becoming an integral part of the stretch marks treatment ecosystem.

REGIONAL ANALYSIS

North America led the global stretch marks treatment market with an estimated 38.9% share, driven by high awareness about aesthetic treatments, well-established dermatology infrastructure, and strong presence of major skincare brands. The United States, in particular, accounts for the majority of this regional dominance due to its robust healthcare system and high consumer spending on cosmetic procedures.

Also, the country also saw a surge in at-home skincare device sales, particularly among millennials and Gen Z consumers who prioritize preventive care and appearance maintenance.

Canada contributes to the regional market through expanding medical spa networks and government-backed initiatives promoting safe and regulated aesthetic treatments. With ongoing technological innovation and widespread acceptance of body-conscious beauty trends, North America remains the most lucrative region in the global stretch marks treatment industry.

Europe is another major player in the global stretch marks treatment sector at 27.5%, supported by a mature cosmetics industry, high disposable income levels, and a growing emphasis on dermatological wellness. Countries such as Germany, France, and the UK serve as key contributors, with established medispa chains and premium skincare brands shaping consumer behavior.

According to the European Society of Aesthetic Plastic Surgeons (ESAPS), over 1.8 million non-surgical aesthetic treatments were performed across Europe in 2023, with skin resurfacing and stretch mark reduction gaining traction among women aged 25–45.

Germany stands out for its integration of biotech-derived skincare solutions, while France remains a hub for luxury cosmeceutical development. Also, regulatory frameworks such as the EU Cosmetics Regulation ensure product safety, fostering consumer confidence in both professional and home-use treatments. With strong brand presence and evolving treatment options, Europe continues to be a key player in the global market.

Asia-Pacific is an attractive region in the global stretch marks treatment market, with countries like India, China, Japan, and South Korea witnessing rising demand due to shifting beauty standards, urbanization, and increasing awareness about dermatological care. The region’s rapid economic growth and rising middle-class population have led to greater investment in personal grooming and aesthetic medicine.

Moreover, the country’s booming e-commerce sector has further facilitated access to international skincare brands and home-use devices, enabling broader consumer participation.

China has seen a surge in demand for Korean and Japanese beauty innovations, including anti-stretch mark creams and serums enriched with botanical extracts. Meanwhile, Japan maintains a strong focus on preventative skincare, with companies like Shiseido and Kose introducing targeted formulations aimed at improving skin elasticity and minimizing scarring. As awareness expands and treatment affordability improves, the Asia-Pacific region is expected to maintain steady growth in the stretch marks treatment space.

Latin America represents notable share of the global stretch marks treatment market, with Brazil, Mexico, and Argentina leading the way in both clinical and consumer-led interventions. The region benefits from a growing aesthetic surgery and skincare industry, particularly in urban centers where body image consciousness is rising.

Brazil plays a pivotal role, given its long-standing reputation for aesthetic excellence. Clinics in São Paulo and Rio de Janeiro have incorporated laser and radiofrequency technologies to address stretch marks, especially post-weight loss and pregnancy-related concerns.

Mexico has also seen a rise in demand for non-invasive aesthetic treatments, bolstered by cross-border collaborations with U.S.-based dermatology firms. As social media influences beauty perception and disposable incomes rise, Latin America presents untapped potential for expansion in the stretch marks treatment domain.

The Middle East and Africa collectively account for descent portion of the global stretch marks treatment market, with the UAE, Saudi Arabia, and South Africa serving as key growth centers. While traditionally conservative in aesthetic preferences, these markets are witnessing a shift toward body-positive beauty trends and increased investment in dermatological wellness.

In the UAE, the Ministry of Health and Prevention has been promoting skin health awareness programs, contributing to higher acceptance of corrective treatments. Dubai and Abu Dhabi have become regional hubs for medical tourism, attracting patients seeking advanced skincare procedures including laser-based stretch mark reduction. South Africa benefits from a well-developed private healthcare system and a growing demand for aesthetic treatments, particularly among younger demographics. While still relatively small compared to other regions, the MEA market shows promising signs of growth as awareness and accessibility improve.

KEY MARKET PLAYERS AND COMPETITIVE LANDSCAPE

Some of the notable companies operating in the global stretch marks treatment market profiled in the report are Clarins Group, Cynosure, Inc., Merz North America, Inc., Laboratoires Expanscience, Union-Swiss (Pty) Ltd., Basq Skincare, The Boppy Company, Helix BioMedix, Inc., Weleda AG and Dermaclara, Inc.

The competition in the stretch marks treatment market is highly fragmented, encompassing pharmaceutical giants, cosmetic companies, dermatological device manufacturers, and emerging direct-to-consumer skincare brands. While multinational corporations dominate the clinical and premium skincare segments, a growing number of startups and independent beauty-tech firms are gaining traction with innovative at-home solutions. This dynamic landscape fosters continuous product development and aggressive marketing efforts to capture consumer interest.

Major players compete not only on product efficacy but also on branding, digital engagement, and accessibility. Established skincare brands emphasize scientific validation and physician endorsements to reinforce credibility, whereas newer entrants leverage e-commerce and AI-powered skin diagnostics to attract tech-savvy users. The rise of telemedicine and virtual consultations further intensifies competition, allowing consumers to compare treatments from home without visiting a clinic.

Additionally, differentiation through ingredient sourcing, sustainability practices, and personalized formulations is becoming a key battleground. As more individuals seek non-invasive solutions for stretch marks, companies must balance affordability with performance to maintain relevance. Regulatory scrutiny around advertising claims also influences market positioning, pushing firms toward transparent labeling and data-backed assertions. In this evolving environment, innovation, strategic alliances, and customer-centric approaches will define long-term success in the stretch marks treatment sector.

Top Players in the Market

Johnson & Johnson (Neutrogena)
Johnson & Johnson, through its subsidiary Neutrogena, plays a significant role in the global stretch marks treatment market by offering dermatologist-tested skincare products designed to improve skin texture and elasticity. The company’s commitment to science-backed formulations has made its anti-stretch mark creams and oils popular among consumers seeking over-the-counter solutions.

Neutrogena's product line includes retinol-based treatments, hyaluronic acid-infused lotions, and bio-renew oil blends that target early-stage striae. Its emphasis on accessibility and affordability has enabled widespread consumer adoption across North America, Europe, and Asia-Pacific. By leveraging its strong brand presence and extensive distribution network, Johnson & Johnson continues to influence both retail and clinical segments of the stretch marks treatment industry.

Shiseido Company Limited
Shiseido is a leading player in the stretch marks treatment market, particularly in the Asia-Pacific region, where it offers premium skincare solutions aimed at improving skin firmness and reducing the visibility of stretch marks. Known for its research-driven approach, the company integrates traditional botanical ingredients with modern biotechnology to enhance skin repair mechanisms.

Through brands like Biotherm and BareMinerals, Shiseido delivers targeted stretch mark prevention and treatment products enriched with peptides, ceramides, and plant extracts. These formulations are backed by clinical studies and tailored for different skin types and life stages, including pregnancy and post-weight loss. With a strong focus on innovation and sustainability, Shiseido remains a key contributor to the evolving landscape of cosmetic dermatology worldwide.

Cynosure, Inc. (A Hologic Company)
Cynosure, now part of Hologic, is a major player in professional-grade stretch marks treatment technologies, specializing in laser and light-based aesthetic devices. Its advanced platforms such as the SmartXide Dot CO2 laser and PicoSure picosecond laser have been widely adopted by dermatologists and medispas globally for their ability to stimulate collagen production and improve skin texture.

The company supports healthcare providers with comprehensive training, technical support, and regulatory compliance guidance to ensure optimal treatment outcomes. By collaborating with aesthetic clinics and research institutions, Cynosure contributes to expanding the reach of laser-based stretch marks treatments beyond high-end medical spas into mainstream dermatology practice. As demand for non-invasive procedures grows, Cynosure’s technology continues to shape clinical approaches to skin rejuvenation.

Top Strategies Used by Key Market Participants

One of the primary strategies employed by key players in the stretch marks treatment market is product diversification and formulation customization. Companies are developing a wide range of topical and device-based treatments tailored to different demographics, including pregnant women, weight-loss patients, and athletes, ensuring broader market appeal and personalized care.

Another key approach is strategic partnerships with dermatologists, influencers, and telehealth platforms , which help build credibility and drive consumer awareness. Brands collaborate with skincare professionals to endorse products while leveraging social media influencers to engage younger audiences who seek effective yet accessible treatment options.

Lastly, investment in clinical research and evidence-based marketing has become essential for gaining consumer trust and regulatory approval. Leading firms conduct controlled trials to validate efficacy claims, supporting both over-the-counter and professional treatment offerings with scientific backing to differentiate themselves in a competitive marketplace.

RECENT HAPPENINGS IN THE MARKET

In March 2024, Neutrogena launched a new line of stretch marks-targeted serums featuring encapsulated retinoids designed to enhance absorption and minimize irritation, aligning with increasing consumer demand for active skincare ingredients backed by dermatological expertise.

In June 2024, Shiseido expanded its partnership with a South Korean biotech firm to develop next-generation peptide-rich topical treatments for stretch marks, focusing on bioengineered compounds that stimulate dermal regeneration and improve skin resilience.

In September 2024, Hologic (formerly Cynosure) introduced an updated version of its PicoSure laser system optimized for treating early-stage striae, incorporating enhanced pigment targeting capabilities and reduced treatment durations to improve patient satisfaction and clinic efficiency.

In November 2024, Perrigo Company launched a direct-to-consumer subscription model for its stretch marks cream line, allowing users to receive monthly supplies along with personalized skincare advice via an integrated mobile app, reinforcing customer retention and brand loyalty.

In January 2025, L’Oréal introduced an AI-powered skin assessment tool within its official website, enabling users to upload images of their skin and receive customized recommendations for stretch mark treatments based on severity, skin type, and lifestyle factors, enhancing user engagement and product relevance.

MARKET SEGMENTATION

This market research report on the global stretch marks treatment market has been segmented based on treatment, end-user, and region.

By Treatment

• Laser
• Microdermabrasion

By End User

• Clinics
• Home-use products

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• The Middle East and Africa